^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Vulvar Cancer |
| Drug: | erlotinib (EGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/26/2021
Excerpt:
Vulvar cancer (Squamous cell carcinoma): Advanced or recurrent/metastatic disease…Other recommended regimens…Erlotinib (category 2B)
